publicações selecionadas
-
artigo académico
- Enhancing precision in sarcoma diagnosis: nCounter fusion panel implementation in a middle-income country. Therapeutic Advances in Medical Oncology. 2025
- Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study. Journal of Neuro-Oncology. 2022
- A Unique Case Report of Infant-Type Hemispheric Glioma (Gliosarcoma Subtype) with TPR-NTRK1 Fusion Treated with Larotrectinib. Pathobiology. 2022
- Simultaneous analysis of ALK, RET, and ROS1 gene fusions by NanoString in Brazilian lung adenocarcinoma patients. Translational Lung Cancer Research. 2021
- EGF +61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients. Thoracic Cancer. 2020
- Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations.. Acta Cytologica. 2019
- EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population.. Molecular Biology Reports. 2019
- Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology.. BMC Pulmonary Medicine. 2017
- Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker. Cellular Oncology. 2016
-
documento